Jungbunzlauer
Premium PartnerIs this your company? Claim this profile
Excipients & Specialty Ingredients
Company Overview
About
Jungbunzlauer is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Austria
Founded:2004
Employees:1,174
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
Jungbunzlauer Ladenburg GmbH
Am Hafen 18, Ladenburg, DE-, 68526
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval 39DL8X
EMA · #APR-JPOA4G14 · 2018-10-01
Drug Approval DNWMN5
Health Canada · #APR-HAE144TU · 2022-03-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-0T1ZTCV5
Issued: 2020-10-20
Expires: 2025-02-04
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-Z790JCSW
Issued: 2020-02-03
Expires: 2025-05-24
Health Canada GMP
Health Canada
Cert #: CERT-NOO5SYIK
Issued: 2020-01-23
Expires: 2025-12-23
Loading CDMO intelligence...
Key facts about Jungbunzlauer
- Jungbunzlauer is headquartered in Austria.
- Jungbunzlauer was founded in 2004.
- Jungbunzlauer has 1,174 employees.
- Jungbunzlauer has one manufacturing site listed on CDMO Hub, in Ladenburg, Germany.
- Jungbunzlauer's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Jungbunzlauer
Directory pages this company appears in, each with the full list of matching manufacturers.